Ionis Historical Cash Flow
| IONS Stock | USD 41.97 1.12 2.60% |
Analysis of Ionis Pharmaceuticals cash flow over time is an excellent tool to project Ionis Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 1.1 B or Depreciation of 23.6 M as it is a great indicator of Ionis Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Ionis Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ionis Pharmaceuticals is a good buy for the upcoming year.
Ionis |
About Ionis Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Ionis balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Ionis's non-liquid assets can be easily converted into cash.
Ionis Pharmaceuticals Cash Flow Chart
Ionis Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Ionis Pharmaceuticals Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Ionis Pharmaceuticals' Investments are comparatively stable compared to the past year. Change Receivables is likely to gain to about 42.6 M in 2024, despite the fact that Change In Working Capital is likely to grow to (73.4 M). Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Ionis Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Ionis Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Ionis Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Ionis Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ionis Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.At this time, Ionis Pharmaceuticals' Investments are comparatively stable compared to the past year. Change Receivables is likely to gain to about 42.6 M in 2024, despite the fact that Change In Working Capital is likely to grow to (73.4 M).
Ionis Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Ionis Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ionis Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 404.5M | (285.6M) | 471.5M | (592.7M) | 122.8M | 128.9M | |
| Free Cash Flow | 309.4M | (5.2M) | 12.9M | (294.5M) | (335.5M) | (318.7M) | |
| Change In Working Capital | (168.7M) | (73.6M) | (113.8M) | 7.6M | (77.3M) | (73.4M) | |
| Begin Period Cash Flow | 278.8M | 683.3M | 397.7M | 869.2M | 276.5M | 154.8M | |
| Other Cashflows From Financing Activities | 203.3M | (558.1M) | 570.0M | (29K) | 1.1B | 1.1B | |
| Depreciation | 16.0M | 17.2M | 19.6M | 22.1M | 22.5M | 23.6M | |
| Other Non Cash Items | 55.7M | 35.7M | 7.7M | (134.6M) | 29.9M | 31.4M | |
| Capital Expenditures | 36.3M | 41.0M | 17.9M | 20.1M | 28.0M | 29.4M | |
| Total Cash From Operating Activities | 345.7M | 35.9M | 30.8M | (274.4M) | (307.5M) | (292.1M) | |
| Net Income | 303.3M | (486.8M) | (28.6M) | (269.7M) | (366.3M) | (348.0M) | |
| Total Cash From Financing Activities | 100.0M | (596.6M) | 245.9M | (55.3M) | 644.1M | 676.3M | |
| End Period Cash Flow | 683.3M | 397.7M | 869.2M | 276.5M | 399.3M | 419.2M | |
| Change To Account Receivables | (44.2M) | (22M) | 5.1M | 36.4M | (72.1M) | (68.5M) | |
| Change To Liabilities | 23.4M | (5.7M) | (42.6M) | 64.4M | 74.0M | 77.7M | |
| Stock Based Compensation | 146.6M | 230.1M | 120.7M | 100.3M | 105.8M | 58.6M | |
| Change To Inventory | (5.4M) | (1.3M) | (2.8M) | 2.8M | (6.4M) | (6.1M) | |
| Total Cashflows From Investing Activities | (41.3M) | 274.5M | 194.9M | (262.6M) | (236.4M) | (224.6M) | |
| Sale Purchase Of Stock | (34.4M) | (90.5M) | (16.7M) | (11.0M) | (9.9M) | (9.4M) | |
| Investments | (5.0M) | 315.5M | 212.8M | (262.6M) | 24.7M | 26.0M | |
| Net Borrowings | (22.1M) | 313.6M | 418.3M | (50.7M) | (58.3M) | (55.4M) | |
| Cash And Cash Equivalents Changes | 404.5M | (285.6M) | 471.5M | (592.3M) | (533.1M) | (506.4M) | |
| Cash Flows Other Operating | (183.1M) | (64.9M) | (66.7M) | (204.3M) | (183.9M) | (174.7M) | |
| Other Cashflows From Investing Activities | (5.4M) | (5.9M) | (5.9M) | 249.7M | 287.2M | 301.5M | |
| Change To Netincome | 161.3M | 528.8M | 130.9M | 103.0M | 118.5M | 87.2M | |
| Change To Operating Activities | (20.1M) | 50.8M | (36.2M) | 32.4M | 37.2M | 39.1M | |
| Issuance Of Capital Stock | 119.7M | 52.0M | 11.6M | 6.4M | 9.0M | 8.6M |
Ionis Pharmaceuticals Investors Sentiment
The influence of Ionis Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ionis. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ionis Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ionis. The trend in average sentiment can be used to explain how an investor holding Ionis can time the market purely based on public headlines and social activities around Ionis Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ionis Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ionis Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ionis Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ionis Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ionis Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ionis Pharmaceuticals' short interest history, or implied volatility extrapolated from Ionis Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ionis Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Ionis Stock analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Ionis Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ionis Pharmaceuticals. If investors know Ionis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ionis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.44) | Earnings Share (2.56) | Revenue Per Share 5.501 | Quarterly Revenue Growth 1.136 | Return On Assets (0.08) |
The market value of Ionis Pharmaceuticals is measured differently than its book value, which is the value of Ionis that is recorded on the company's balance sheet. Investors also form their own opinion of Ionis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ionis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ionis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ionis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ionis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ionis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ionis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.